H
Hirotsu Bio Science
Biotech & Life Sciences · Tokyo, Japan · Founded 2016
Developed N-Nose, a non-invasive cancer screening product using nematode worms to detect early-stage cancers through urine samples MoreLess
Hirotsu Bio Science is a pioneering biotechnology company specializing in cancer diagnostics and treatment. The company leverages advanced nematode-based technology to detect cancer at early stages, providing a significant advantage in personalized treatment plans. Operating primarily in the healthcare and biotechnology sectors, Hirotsu Bio Science serves medical institutions, research organizations, and healthcare providers. The company's business model revolves around the development and commercialization of diagnostic tests, particularly the N-NOSE test, which uses nematodes to detect cancer biomarkers in urine samples. Revenue is generated through the sale of these diagnostic tests and related services.
Hirotsu Bio Science's market includes both domestic and international clients, with a focus on expanding its reach globally. The company aims to revolutionize cancer diagnostics by offering a non-invasive, accurate, and cost-effective solution for early cancer detection. By integrating cutting-edge research with practical applications, Hirotsu Bio Science is positioned to make a significant impact on the healthcare industry.
Keywords: cancer diagnostics, nematode technology, early detection, personalized treatment, N-NOSE test, biotechnology, healthcare, medical institutions, non-invasive, biomarkers.
Company overview
Hirotsu Bio Science company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2016
- Headquarters
- Tokyo, Japan
- Employees
- 12
- Open positions
- None listed
- Dealroom signal
- 69.3
Valuation & funding
Hirotsu Bio Science funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Aug 2024 | $0 | — | Eastern Car Liner | ↗ |
| LATE VCOther financing | Dec 2023 | $0 | — | Dynamite Brother Senshidkate · NPH Holdings | — |
| LATE VCOther financing | Aug 2022 | $716K | $2.9M | Undisclosed | — |
| LATE VCOther financing | Jan 2022 | $15K | $62K | Undisclosed | — |
| EARLY VCOther financing | Jul 2021 | $146M | $586M | SBI Investment · MS&AD · Future Venture Capital | ↗ |
| EARLY VCOther financing | Mar 2021 | SBI Investment · Future Venture Capital | ↗ | ||
| EARLY VCOther financing | Mar 2020 | Sompo Holdings | — | ||
| EARLY VCOther financing | Aug 2018 | Iyogin Capital · Toppan Forms · Nippon Broadcasting System · Ichinen Holdings | ↗ | ||
| EARLY VCOther financing | Feb 2018 | Tokyo Kiraboshi Financial Group · Free bank Capital | ↗ | ||
| EARLY VCOther financing | Oct 2017 | Shinkin Capital | ↗ |
Growth signals
Hirotsu Bio Science website traffic
Latest recorded traffic for Hirotsu Bio Science is 15K monthly website visits, up 0% over the last three months. Hirotsu Bio Science's team declined 14.3% over the past year.
Comparisons
Hirotsu Bio Science compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Hirotsu Bio Science's talent
Source: Dealroom Talent Intelligence.
Investors
14 investors on Hirotsu Bio Science's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Hirotsu Bio Science has talent and traffic
team presence
In the news
Latest news about Hirotsu Bio Science
Recent press, funding announcements, and product moves mentioning Hirotsu Bio Science — open to read from the original sources.
Market sentiment
What the market is saying about Hirotsu Bio Science
An AI-synthesized read of the highest-engagement posts about Hirotsu Bio Science on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Hirotsu Bio Science’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.